Abstract: An information processing method, which includes an evaluating step of evaluating at least one item of growth potential, nutrition state of a protein, utilization efficiency of an amino acid, glucose metabolism, stress, appetite, feed efficiency, growth speed, and growth prediction, by using a blood concentration value of at least one amino acid of Asn, Ser, Gly, His, Thr, Arg, Pro, Tyr, Val, Met, Orn, Lys, Ile, Leu, Phe, Trp, and 3Met-His, obtained from an animal, or a value of one or a plurality of formulae that include an explanatory variable to be substituted with the blood concentration value, calculated using the formula and the blood concentration value, wherein at the evaluating step, each evaluation is carried out using the blood concentration value or the value of one formula, is useful for evaluating the health and/or growth state of livestock.

Abstract: Compositions, comprising one or more amino acids selected from the group consisting of tryptophan, methionine, phenylalanine, valine, leucine, histidine, lysine and threonine, and isoleucine at a content of not more than 1.5 wt % relative to the total amount of the nutrition composition, provide a more economical and effective nutrition composition for suppressing the growth of hemocytozoon such as malaria parasite and the like.

Abstract: Methods for reducing excessive barking of a dog are disclosed wherein GABA or SKF97541 is administered.

Abstract: An agent for improving mobility and general health of senior companion animals is provided whereby said agent contains one or more substances selected from the group consisting of a GABAA receptor agonist, a GABAB receptor agonist and a GABAA receptor enhancing substance as an active ingredient. Compositions containing said agent, including a pet food additive and a pet food, as well as methods of administering said compositions to senior companion animals are also provided.

Abstract: A method of fattening fowls comprising the step of administrating one or more running neuron inhibitory substance(s) is provided. Especially, a method of fattening fowls is provided, wherein fowls are administrated by a substance selected from the group consisting of GABAB receptor agonist, GABAA receptor agonist, GABAA receptor enhancer, kainate receptor antagonist and a combination thereof or fowls are provide with a feed comprising the substance or a combination thereof.

Abstract: The present invention provides a pharmaceutical composition and a method for prevent problem behaviors of animals, particularly companion animals. The pharmaceutical composition comprises one or more running neuron inhibiting substances, such as GABAB receptor agonists, GABAA receptor agonists, substances that enhance the activity of GABAA receptor and kainate receptor antagonists, or any combination thereof. The method comprises the step of administrating the pharmaceutical composition of the present invention.

Abstract: It is an object of the present invention to treat a patient suffering from symptoms accompanied by non-intentional motions such as poriomania and hyperkinesia, by administering to the patient a substance capable of pre-synaptically or post-synaptically inhibiting the running neurons. In particular, the running neuron-inhibitory substances include a member selected from the group consisting of kainate receptor antagonists, GABAB receptor agonists, GABAA receptor agonists, and GABAA receptor-enhancing substances, or any combination thereof.

Abstract: It is an object of the present invention to provide a pharmaceutical composition, which permits the inhibition of non-intentional motions such as poriomania and hyperkinesia without any inhibition of intentional motions and in particular to provide a pharmaceutical composition capable of treating patients suffering from, for instance, poriomania and hyperkinesia. Moreover, it is also an object of the present invention to provide a method of using running neuron-inhibitory substances.